C. Garrison Fathman, M.D.

Affiliations: 
Stanford University, Palo Alto, CA 
Website:
https://profiles.stanford.edu/c-fathman
Google:
"C. Garrison Fathman"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kodama K, Zhao Z, Toda K, et al. (2016) Expression-based Genome-Wide Association Study Links Vitamin D Binding Protein with Autoantigenicity in Type 1 Diabetes. Diabetes
Creusot RJ, Battaglia M, Roncarolo MG, et al. (2016) Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes. Stem Cells (Dayton, Ohio). 34: 809-19
Kurnellas MP, Ghosn EE, Schartner JM, et al. (2015) Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease. Proceedings of the National Academy of Sciences of the United States of America
Nair N, Mei HE, Chen SY, et al. (2015) Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy. Arthritis Research & Therapy. 17: 127
Yip L, Fuhlbrigge R, Taylor C, et al. (2015) Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes. Diabetes. 64: 604-17
Kurnellas MP, Schartner JM, Fathman CG, et al. (2014) Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease. The Journal of Experimental Medicine. 211: 1847-56
Yip L, Fathman CG. (2014) Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis. Immunologic Research. 58: 340-50
Creusot RJ, Giannoukakis N, Trucco M, et al. (2014) It's time to bring dendritic cell therapy to type 1 diabetes. Diabetes. 63: 20-30
Yip L, Taylor C, Whiting CC, et al. (2013) Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes. Diabetes. 62: 4208-19
Yip L, Creusot RJ, Pager CT, et al. (2013) Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3. Journal of Molecular Cell Biology. 5: 99-110
See more...